کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
1199090 1493510 2015 11 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
High performance liquid chromatographic enantioseparation development and analytical method characterization of the carboxylate ester of evacetrapib using an immobilized chiral stationary phase with a non-conventional eluent system
ترجمه فارسی عنوان
بررسی عملکرد انانتیسپاراسیون کروماتوگرافی مایع با عملکرد بالا و تعیین روش تحلیلی استریک کربوکسیلات اوااسترپیب با استفاده از یک فاز ثابت کیروال ثابت با سیستم مایع غیر متعارف
موضوعات مرتبط
مهندسی و علوم پایه شیمی شیمی آنالیزی یا شیمی تجزیه
چکیده انگلیسی


• Summary of the benefits of immobilized polysaccharide chiral stationary phases.
• Separation of the methyl ester of evacetrapib from three isomers.
• Fine-tuned conditions that resolves isomers from structurally diverse impurities.
• Ternary eluent system incorporating a mid-polarity solvent.
• Separation method withstood a rigorous characterization and ruggedness protocol.

Using multiple HPLC chromatographic modes and various chiral columns in the context of an automated screening system, a potential separation was initially identified for the methyl ester of evacetrapib and its stereoisomers using an immobilized polysaccharide-based HPLC column. The bonded nature of this column, the Chiralpak® IC, allows for enhanced separation development with a diverse solvent range not amenable to standard coated chiral stationary phases. The ternary eluent system ultimately identified provided isomer resolutions not obtainable via the more established hexane/alcohol or polar organic chromatographic modes. A systematic separation development process is described, first for the resolution of the isomers, and later incorporating five potential impurities. A robust separation system was eventually developed that effectively resolves all compounds within a reasonable analysis time.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Chromatography A - Volume 1416, 16 October 2015, Pages 83–93
نویسندگان
, , , , ,